SCHEMBL1254041

SCHEMBL1254041

CN(C)c1ccc(CC=O)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.58
TSHR P16473 5/20 0.58
MAPK1 P28482 4/20 0.58
CYP3A4 P08684 3/20 0.58
TDP1 Q9NUW8 2/20 0.58
CYP2A6 P11509 1/20 0.54
CYP2A13 Q16696 1/20 0.54
ALOX15 P16050 3/20 0.52
HSD17B10 Q99714 2/20 0.52
TP53 P04637 2/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HIF1A Q16665 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
HBB P68871 1/20 0.41
APP P05067 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27923997 0.81 ALDH1A1 (0.48) ALDH1A1TSHRMAPK1CYP3A4TDP1
SCHEMBL25530598 0.81 ALDH1A1 (0.58) ALDH1A1TSHRMAPK1CYP3A4TDP1
SCHEMBL14889392 0.81 ALDH1A1 (0.58) ALDH1A1TSHRMAPK1CYP3A4TDP1
SCHEMBL6189321 0.80 ALDH1A1 (0.52) ALDH1A1TSHRMAPK1CYP3A4TDP1
SCHEMBL14144804 0.79 ALDH1A1 (0.56) ALDH1A1TSHRMAPK1CYP3A4TDP1
SCHEMBL6364651 0.79 MAOB (0.40) ALDH1A1TSHRCYP3A4TDP1ALOX15
SCHEMBL28534677 0.79 ALDH1A1 (0.50) ALDH1A1TSHRMAPK1CYP3A4TDP1
SCHEMBL570651 0.77 ALDH1A1 (0.63) ALDH1A1TSHRMAPK1CYP3A4TDP1
SCHEMBL18896535 0.77 ALDH1A1 (0.54) ALDH1A1TSHRMAPK1CYP3A4TDP1
SCHEMBL3242751 0.77 ALDH1A1 (0.48) ALDH1A1TSHRMAPK1CYP3A4TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
US-11225655-B2 Bi-functional complexes and methods for making and using such complexes NUEVOLUTION A/S (DK) 2022-01-18 US disclosed
CN-106200264-B White photosensitive resin composition, white matrix, color filter, reflective display device, white frame and display device 奇美实业股份有限公司 2021-02-26 CN disclosed
WO-2020107189-A1 PYRROLIDINE COMPOUNDS FOR THE TREATMENT OF MALARIA LEGION PHARMA CO. LTD (CN) 2020-06-04 WO disclosed
EP-2768918-B1 ADHESIVE SUBSTANCE, IN PARTICULAR FOR ENCAPSULATING AN ELECTRONIC ASSEMBLY TESA SE (DE) 2020-04-29 EP disclosed
WO-2020020190-A1 METHOD FOR SYNTHESIZING QUINOLINE DERIVATIVE 正大天晴药业集团股份有限公司 2020-01-30 WO disclosed
US-20190308398-A1 SELF-HEALING SURFACE PROTECTIVE FILM WITH AN ACRYLATE-FUNCTIONAL TOPCOAT TESA SE (DE) 2019-10-10 US disclosed
EP-3540059-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES Nuevolution A/S (DK) 2019-09-18 EP disclosed
WO-2019147865-A1 A METHOD FOR ENANTIOSELECTIVE CARBENE C-H INSERTION USING AN IRON-CONTAINING PROTEIN CATALYST CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2019-08-01 WO disclosed
EP-2797417-B1 SELECTIVE INHIBITION OF PHOSPHOENOLPYRUVATE CARBOXYLASES OF C4 PLANTS HEINRICH HEINE UNIV DUESSELDORF (DE) 2019-07-31 EP disclosed
WO-2007065940-A1 ANTIPROLIFERATIVE PYRIMIDYL, FUSED PYRIMIDYL AND PYRIMIDYL HYDRAZONES LABORATOIRES SERONO S.A. (CH) 2007-06-14 WO disclosed
WO-2007020046-A1 BENZOQUINAZOLINE DERIVATIVES AND THEIR USE IN TREATING BONE DISORDERS NOVARTIS AG (CH) 2007-02-22 WO disclosed
US-20060257650-A1 Pressure-sensitive adhesives and process for preparing them TESA AKTIENGESELLSCHAFT (DE) 2006-11-16 US disclosed
WO-2006077059-A1 TYRE RUNNING THREAD SOCIETE DE TECHNOLOGIE MICHELIN (FR) 2006-07-27 WO disclosed
WO-2000023444-A1 5,7-DISUBSTITUTED-4-AMINOPYRIDO[2,3-D]PYRIMIDINE COMPOUNDS ABBOTT LABORATORIES (US) 2000-04-27 WO disclosed
EP-0989986-A1 5,7-DISUBSTITUTED 4-AMINOPYRIDO 2,3-D]PYRIMIDINE COMPOUNDS AND THEIR USE AS ADENOSINE KINASE INHIBITORS Abbott Laboratories (US) 2000-04-05 EP disclosed
WO-1998046605-A1 5,7-DISUBSTITUTED 4-AMINOPYRIDO[2,3-D]PYRIMIDINE COMPOUNDS AND THEIR USE AS ADENOSINE KINASE INHIBITORS ABBOTT LABORATORIES (US) 1998-10-22 WO disclosed
EP-0157399-B1 4-(5H-Dibenzo[a,d]cyclohepten-5-yl) piperidine compounds MERCK & CO. INC. (US) 1989-08-16 EP disclosed
US-4758577-A 4-(5H-dibenzo[a,d]cyclohepten-5-yl)piperidine compounds for treating cardiovascular disorders MERCK & CO., INC. (US) 1988-07-19 US disclosed
EP-0157399-A2 4-(5H-Dibenzo[a,d]cyclohepten-5-yl) piperidine compounds MERCK & CO. INC. (US) 1985-10-09 EP disclosed